23 results
8-K
BCRX
Biocryst Pharmaceuticals Inc.
7 Dec 12
Biocryst Pharmaceuticals Announces Focused Corporate Strategy
12:00am
will be substantially complete by December 31, 2012.
The Company’s corporate restructuring includes a workforce reduction of 50 percent
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
7 Dec 12
Biocryst Pharmaceuticals Announces Focused Corporate Strategy
12:00am
corporate restructuring includes a workforce reduction of 50 percent of the Company’s headcount, or 38 positions. Excluding restructuring and deal charges
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
31 Oct 08
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
12:00am
initiatives, including a recent 20 percent reduction in our workforce, to focus the Company’s resources on the execution of our late-stage clinical trials
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
6 May 24
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
7:03am
workforce reduction implemented in the first quarter of 2024.
Based on the company’s disciplined approach to capital allocation, and the adjusted
8-K
EX-99.1
wr614x3zcmcydhhhtj
26 Feb 24
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
7:05am
8-K
EX-99.1
79asjfw5dx3h yk
16 Dec 03
Other events
12:00am
8-K
EX-99.1
6k0s76thv ve5qz
4 Feb 04
Other events
12:00am